A multi-omics and machine learning framework identifies plasma SBDS as a causal biomarker and therapeutic target in primary sclerosing cholangitis – EurekAlert!
A multi-omics and machine learning framework identifies plasma SBDS as a causal biomarker and therapeutic target in primary sclerosing cholangitis – EurekAlert!